[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@EgidiusLambrech Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::404367469.png) @EgidiusLambrech E Lambrechts

E Lambrechts posts on X about $gmab, $abbv, $jnj, r2 the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::404367469/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::404367469/c:line/m:interactions.svg)

- X Week XXX +74%
- X Month XXXXX -XX%
- X Months XXXXXX -XX%
- X Year XXXXXX +2.70%

### Mentions: X [#](/creator/twitter::404367469/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::404367469/c:line/m:posts_active.svg)

- X Week X -XX%
- X Month XX -XX%
- X Months XX +51%
- X Year XXX +54%

### Followers: XXX [#](/creator/twitter::404367469/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::404367469/c:line/m:followers.svg)

- X Week XXX no change
- X Month XXX -XXXX%
- X Months XXX -XXXX%
- X Year XXX +2.70%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::404367469/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::404367469/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  XX%

**Social topic influence**
[$gmab](/topic/$gmab) #2, [$abbv](/topic/$abbv) #44, [$jnj](/topic/$jnj) 20%, [r2](/topic/r2) 10%, [$pfe](/topic/$pfe) 10%, [kan](/topic/kan) XX%

**Top accounts mentioned or mentioned by**
[@genmab](/creator/undefined) [@amsterdamumc](/creator/undefined)

**Top assets mentioned**
[AbbVie Inc (ABBV)](/topic/$abbv) [Johnson & Johnson (JNJ)](/topic/$jnj) [Pfizer, Inc. (PFE)](/topic/$pfe)
### Top Social Posts
Top posts by engagements in the last XX hours

"EPCORE FL-1: Adding #Epcoritamab to R2 Delivers New Benchmark in Second-Line Follicular Lymphoma $GMAB $ABBV #Genmab #AbbVie #Epkinly"  
[X Link](https://x.com/EgidiusLambrech/status/1997941470133940369)  2025-12-08T08:09Z XXX followers, XXX engagements


"#TALVEY (talquetamab) receives positive #NICE recommendation in Final Draft Guidance for treating relapsed and refractory multiple myeloma after three or more lines of treatment $JNJ $GMAB #Genmab #Royalties"  
[X Link](https://x.com/EgidiusLambrech/status/1990715976510329256)  2025-11-18T09:37Z XXX followers, XXX engagements


"Transcript: #Genmab presentation at the Jefferies Healthcare Conference Fireside Chat with Chief Executive Officer Jan van de Winkel and Chief Financial Officer Anthony Pagano. $GMAB via"  
[X Link](https://x.com/EgidiusLambrech/status/1992925003936043128)  2025-11-24T11:55Z XXX followers, XXX engagements


"#Genmab $GMAB #Royalties"  
[X Link](https://x.com/EgidiusLambrech/status/1992990601680482354)  2025-11-24T16:16Z XXX followers, XXX engagements


"#Genmab $GMAB #AbbVie $ABBV epcoritamab #Epkinly"  
[X Link](https://x.com/EgidiusLambrech/status/1995504112906187081)  2025-12-01T14:43Z XXX followers, XXX engagements


"MHRA (UK) approves #tisotumab vedotin for the treatment of cervical cancer #Tivdak #Genmab #Pfizer $GMAB $PFE"  
[X Link](https://x.com/EgidiusLambrech/status/1995889537545851360)  2025-12-02T16:15Z XXX followers, XX engagements


"#Epcoritamab offers new hope for patients with #Richter Transformation - one of the most aggressive and difficult-to-treat forms of lymphoma. $GMAB $ABBV @Genmab #AbbVie #Epkinly @amsterdamumc"  
[X Link](https://x.com/EgidiusLambrech/status/1998683649600831939)  2025-12-10T09:18Z XXX followers, XX engagements


"#Epcoritamab kan blive en gamechanger i behandlingen af #Richters transformation $GMAB $ABBV @Genmab #AbbVie #Epkinly"  
[X Link](https://x.com/EgidiusLambrech/status/1998690595259216320)  2025-12-10T09:45Z XXX followers, XX engagements


"Unprecedented results from the Phase X MajesTEC-3 study support #TECVAYLI plus #DARZALEX FASPRO as a potential standard of care as early as second line for patients with R/R multiple myeloma $JNJ $GMAB #Genmab #Royalties"  
[X Link](https://x.com/EgidiusLambrech/status/1998398080215904705)  2025-12-09T14:23Z XXX followers, XXX engagements